Clinical Trial Update: Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan [Phase 2]

View source ↗

Summary

This update confirms that the rollover/continued-access protocol for Tenofovir Disoproxil Fumarate in hepatitis B patients in Taiwan has completed a Phase 2 tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED